S tudies in intensive care units (ICUs) suggest that up to 50% of critically ill obstetric patients have neurologic involvement (1) (2) (3) . Neurologic manifestations may result from a variety of obstetric illnesses, including eclampsia, acute fatty liver of pregnancy, and amniotic fluid embolism (4) . In some patients, preexisting medical disorders such as hypertension, rheumatological disorders, or intracranial neoplasms may worsen during pregnancy or puerperium, resulting in critical illness (5) (6) (7) (8) . Pregnancy itself may predispose to some medical conditions that could also occur in nonpregnant patients but may increase their severity. These include cerebral venous sinus thrombosis, viral hepatitis E infection, and falciparum malaria (1, 2, 4) . This article reviews the important neurologic syndromes that occur in critically ill pregnant patients and discusses the common conditions that cause these syndromes. Aspects of these diseases and their management that require special consideration for pregnant patients will also be highlighted.
NEUROLOGICAL SYNDROMES Altered Mental Status and Coma
Altered consciousness is the commonest neurologic manifestation seen in obstetric patients in the ICU (1, 2) . At least two studies have shown that the extent of neurologic involvement defined by the Glasgow Coma Scale (GCS) is an independent predictor of maternal mortality (2, 9) . Women with neurologic failure, defined by a Glasgow Coma Scale score Յ8, had an odds ratio of 4.7 for risk of death, in comparison with patients whose score was Ͼ8. Common causes of coma are listed in Table 1 . The presence of focal neurologic deficits and signs of meningeal irritation help in the clinical diagnosis of the cause of coma. Common disorders producing coma along with focal neurologic deficits are cerebral infarction, intracerebral hemorrhage, cerebral venous sinus thrombosis, brain abscess, and cerebral neoplasms. Coma with signs of meningeal irritation will be present in bacterial, tuberculous, or fungal meningitis and subarachnoid hemorrhage. Imaging of the brain with computed tomography (CT) or magnetic resonance imaging (MRI) or examination of cerebrospinal fluid will confirm the diagnosis. Absence of focal deficits and meningeal signs suggests a metabolic or toxic cause or the presence of a systemic infection (septic encephalopathy, cerebral malaria).
Seizures
The commonest cause of seizures during pregnancy is preexisting epilepsy (10 -12) . New-onset seizures with normal blood pressure should be investigated to exclude cerebral parenchymal disorders and metabolic derangements such as hyponatremia or hypoglycemia (10) . Presence of hypertension points to a diagnosis of eclampsia. Fulminant hepatic failure due to acute fatty liver of pregnancy or acute viral hepatitis may also cause seizures and coma (13) .
or neuromuscular junction disorders. Spinal cord involvement due to trauma or demyelination may occur (multiple sclerosis or acute transverse myelitis) (12, 14) . Peripheral neuropathy due to the Guillain-Barre syndrome or porphyria may occur, and some patients may experience a worsening of myasthenia gravis during pregnancy (10, 14 -16) . These disorders may often be severe enough to require mechanical ventilation. Moreover, muscle weakness may also interfere with maternal effort during delivery.
COMMON NEUROLOGICAL DISORDERS Epilepsy
It is estimated that 7% of epileptic patients become pregnant and 0.5% of all pregnancies are complicated by epilepsy (12) . In a study in Helsinki, 22% of 784 patients with grand mal epilepsy had at least one seizure during pregnancy (17) . Approximately one-third of patients experience a worsening of seizure control during pregnancy; patients with poor control before pregnancy are more likely to have increased seizure frequency during pregnancy (11, 18) . This may be due to psychological stress, altered drug disposition, or poor compliance due to fear of teratogenicity (11) . Elevated estrogen levels may reduce the seizure threshold (19) . Serum levels of antiepileptic drugs may decline during pregnancy because of a larger volume of distribution, reduced plasma protein binding, increased renal clearance, hepatic microsomal enzyme induction, and impaired intestinal absorption (11, 12, 19) . Other factors include use of folate supplementation, anxiety, stress, sleep deprivation, and metabolic changes (12, 17, 20) . Fear of fetal malformations associated with antiepileptic drugs also may result in noncompliance with drug therapy (20) .
Maternal seizures result in severe lactic acidosis, increased cardiac output, transient elevation of blood pressure, increased intra-abdominal pressure, and redistribution of blood flow to the brain and muscles, with consequent decrease in visceral and uterine blood flow (10, 17) . Although a single maternal seizure does not seem to have a direct adverse effect on the healthy fetus (17) , status epilepticus is associated with high maternal as well as fetal mortality. In a series of 29 patients, 9 mothers and 14 fetuses died during or shortly after an episode of status epilepticus (20) .
Perinatal mortality is 1.2 to three times higher among patients with epilepsy (21) . Other fetal complications in patients with epileptic seizures include stillbirth, prematurity, perinatal death, congenital anomalies (associated with antiepileptic drugs), hemorrhagic diseases of the newborn, intracranial hemorrhage, and low Apgar scores (12, 14, 17, 20) . Data from the Confidential Enquiries into Maternal Deaths in the United Kingdom from 1985 to 1999 suggest that epilepsy is an important indirect cause of maternal deaths, and many of these deaths are seizure-related (14, 17) . Women with epilepsy have an increased incidence of hyperemesis gravidarum, preeclampsia, premature labor, instrumental deliveries, and cesarean section (11, 20) .
The risk of developing a seizure during labor is nine times that during the rest of pregnancy (17) . A seizure during labor can result in profound fetal bradycardia that may last for as long as 20 mins (17, 20) . These infants may have neonatal hypoxia and low Apgar scores as well (22) . Trauma associated with seizures may rarely cause ruptured fetal membranes or placental abruption (11, 20) .
Seizures during pregnancy should be treated aggressively. The patient must be placed in a left lateral position to increase uterine blood flow and prevent aspiration (10, 20) . Oxygen should be administered. Intravenous lorazepam administered as 2-mg boluses, repeated every 5 mins if required, is the preferred drug for treating tonic-clonic seizures during pregnancy (11, 20) . Diazepam in 5-to 10-mg boluses is an alternative (11) . Blood should be drawn for determination of levels of blood glucose, electrolytes, calcium, and antiepileptic drugs (10, 11) . Fifty milliliters of 50% glucose should be administered promptly, along with thiamine (100 mg) if alcoholism is suspected (10) . Simultaneously, a loading dose of phenytoin (18 mg/kg intravenously at a rate not exceeding 50 mg/min) is administered to patients who are not already receiving oral phenytoin. Intravenous magnesium is preferred over phenytoin if the seizures are due to eclampsia (10) . Intravenous phenobarbital or benzodiazepine infusions may be required if seizures recur, but these drugs can depress the level of consciousness in the mother, and tracheal intubation is usually required (11) . They may also produce respiratory depression in the mother as well as the newborn (11) . Although patients who have seizures during pregnancy may deliver normally, a seizure during labor usually necessitates delivery by cesarean section because of the risk of fetal hypoxia and acidosis and the inability of the mother to cooperate during vaginal delivery because of altered mental status due to seizures and drugs (20) . Meperidine is best avoided as an analgesic because it may lower the seizure threshold (20) .
Measures to prevent seizures during pregnancy must be emphasized during prenatal visits. The benefits of seizure prevention must be balanced against the teratogenic risk of antiepileptic drugs (19, 20) . Women should preferably be on a single antiepileptic agent (23) . Regular therapeutic drug monitoring of antiepileptic drug levels (preferably unbound drug levels) should be done (17, 19, 23) . Sleep deprivation should be avoided. Folate supplements should be started, preferably before pregnancy, in order to reduce risk of fetal malformations (14, 23) . Regular prenatal monitoring for fetal malformations with appropriate blood tests, ultrasonography, and other modalities should be performed (20, 23) .
Intracranial Neoplasms
Different histologic types of brain tumors occur with the same frequency in pregnancy as they do in age-matched nonpregnant patients (24) . Gliomas are the commonest tumors in pregnant patients and account for 38% of all primary brain tumors, followed by meningiomas (28%) and acoustic neuromas (14%) (24) . Most brain tumors expand considerably during pregnancy and often manifest for the first time in pregnant patients (11, 24, 25) . Peritumoral edema can worsen as a result of a generalized increase in intracellular and extracellular fluid compartments in the late second and third trimesters (10, 24, 25) . Moreover, 70% to 90% of meningiomas express highaffinity progesterone receptors (24) . Thirty-five percent of meningiomas and 50% to 100% of acoustic neuromas also have estrogen receptors (24, 25) . Hormonal changes in pregnancy could therefore promote tumor growth by acting on these receptors (10 -12, 24, 25) .
Headache, vomiting, visual symptoms, focal neurologic deficits, and seizures are common symptoms of primary brain tumors. The diagnosis is made by neuroimaging with MRI or CT scanning. In general, MRI scans are preferred because of better tissue resolution and because the magnetic field used is safe and does not affect the fetus (24) . Gadolinium, the contrast material used for MRI scans, is also safe in pregnancy. CT scans are more widely available and are still commonly used, after shielding of the abdomen to prevent radiation exposure in the fetus. The contrast agent used during CT scanning crosses the placenta and may very rarely cause hypothyroidism in the fetus (24) .
Most intracranial neoplasms are treated by surgical excision. However, surgery in benign tumors such as meningiomas and acoustic neuromas and also in slowly growing low-grade malignant tumors such as gliomas may be deferred until after delivery (10, 11, 24) . Symptoms due to pressure on surrounding structures or raised intracranial tension are treated with corticosteroids to reduce tumor edema (10, 24) . Prednisone is preferred over dexamethasone because it is metabolized before it crosses the placenta (25) . Anticonvulsants are administered to prevent seizures. If the patient continues to worsen despite maximum conservative measures, surgical excision should be undertaken, regardless of the stage of pregnancy (24) . High-grade gliomas, on the other hand, are surgically excised during pregnancy, unless the patient is near term and delivery by induction of labor or cesarean section is planned (24, 25) . Adjuvant implantable or systemic chemotherapy and radiotherapy are often used (25) . These modalities are extremely harmful to the fetus and should be administered only after weighing the risk and benefits (24) .
Prolactinomas are the commonest pituitary tumors in these patients, and they enlarge considerably during pregnancy (12, 24) . Macroadenomas may cause symptomatic compression of the optic chiasma and optic nerves (11) . Bromocriptine, a dopamine agonist, can decrease the size of the tumor by up to 50% and may be administered during pregnancy (11, 24) . Transsphenoidal resection could be undertaken safely in pregnant patients in whom the tumor continues to grow, causing worsening visual symptoms (12, 24) . After delivery, most prolactinomas regress to a large extent, and further treatment can be planned accordingly (24) .
Intracranial pressure can increase to as high as 70 cm H 2 O (normal ϭ 20 cm H 2 O) during the second stage of labor because of the bearing down efforts and forceful uterine contractions (10, 24) . This can potentially contribute to cerebral herniation in patients with brain tumors with raised intracranial tension. Therefore, some experts consider vaginal delivery to be contraindicated for patients with raised intracranial pressure (24) . Others permit vaginal delivery with forceps or vacuum to shorten the second stage (11) .
Eclampsia
Eclampsia is defined as the development of seizures during the pregnancy or postpartum period in patients with preeclampsia. Although preeclampsia occurs in 6% to 8% of pregnancies, the incidence of eclampsia in developed countries has decreased to 0.04% to 0.1% (26) . In developing countries, the incidence is much higher (27, 28) . Eclampsia accounted for 14% of obstetric ICU admissions in Indian public hospitals and 66% of all obstetric ICU admissions in South Africa (1, 3) . In another study comparing obstetric patients admitted to an American ICU and an Indian ICU, seizures were nine times more frequent in Indian patients than in American patients, probably because of better prenatal care in the latter group (1). Eclampsia is even more common in African countries, and approximately 50,000 deaths due to eclampsia occur annually worldwide (3, 26) .
The exact mechanism of ecliptic convulsions is not clear (10, 26, 27) . Postulated mechanisms include cerebral vasospasm, hypertensive encephalopathy, breakdown of cerebral autoregulation, cerebral edema, cerebral microhemorrhages, and metabolic encephalopathy (27) . It is now clear that severe preeclampsia can affect several organ systems other than the brain, including the liver, kidneys, coagulation (4, 26) . Thus, eclampsia represents just one of the complications of severe preeclampsia.
It is difficult to predict which preeclamptic patients will develop eclamptic seizures. Occipital or frontal headaches precede seizures in 50% to 75% of patients, and 20% to 30% have visual blurring or cortical blindness (27) . While little over 50% of patients develop convulsions in the antepartum period and 20% in the intrapartum period, about 11% to 44% develop seizures in the postpartum period (27) . The diagnosis is made by the presence of hypertension, proteinuria, and edema, along with seizures occurring after 20 wks of pregnancy. However, up to 16% of patients may have normal blood pressure, and proteinuria is absent in 14% (27) . Cerebral imaging with CT or MRI scans reveals cerebral edema. Some patients may have classic reversible posterior leukoencephalopathy, which is characterized by bilaterally symmetrical edema in the white matter in the posterior portions of the cerebral hemispheres, especially in the parieto-occipital regions (29) . The calcarine and paramedian occipital lobe structures are spared. This condition should be differentiated from infarction in the bilateral posterior cerebral artery territory, where the calcarine, thalamic, and midbrain regions are usually affected (29) . Cerebral imaging is not routinely performed in eclampsia. However, other causes of seizures must be excluded for patients with focal deficits, prolonged coma, and onset of seizures before 20 wks of gestation or Ͼ48 hrs after delivery (27) .
Eclamptic patients require intensive care for the neurologic manifestations and also for other coexisting conditions, which include placental abruption, dis-seminated intravascular coagulation, acute pulmonary edema, acute renal failure, HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets), intracranial hemorrhage, and aspiration pneumonia (4) . After management of the initial seizure, the next step in management is to prevent recurrence of seizures. Magnesium sulfate is the drug of choice for this purpose (26, 27) . The international Eclampsia Trial Collaborative Group study randomly allocated 1,687 patients with eclampsia to two treatment groups: one group received magnesium sulfate or diazepam, and the other received magnesium sulfate or phenytoin (30) . This study showed that patients treated with magnesium sulfate had a 52% lower incidence of recurrent convulsions than patients receiving diazepam and a 67% lower incidence than those receiving phenytoin (30) .
The most commonly used intravenous regimen consists of an initial dose of 4 -6 g of magnesium sulfate over 20 mins, followed by an infusion of 2 g/hr (26, 27) . The intramuscular regimen consists of an initial dose of 10 g of 50% magnesium sulfate administered as 5 mL in each buttock, followed by 5 g intramuscularly every 4 hrs. Magnesium levels may be measured after 6 hrs (therapeutic level, 4 -8 mEq/L) if patellar reflexes are absent or if urine output falls below 100 mL in 4 hrs (26) . For patients whose seizures recur, 2-4 g of magnesium sulfate may be infused over 5-10 mins (27, 30) . In cases of cardiac arrhythmia due to magnesium toxicity, 10 mL of 10% calcium gluconate is infused over 3 mins (26, 27) . Respiratory depression should be looked for and treated by mechanical ventilation (26) .
If blood pressure remains Ͼ160/110 mm Hg after magnesium therapy is instituted, antihypertensive drugs may be needed to prevent left-ventricular failure and intracranial hemorrhage (27, 31) . Blood pressure should not be allowed to decrease to Ͻ140/90 mm Hg to maintain already compromised cerebral and uteroplacental perfusion (27) . Intravenous hydralazine or labetalol may be used. Sublingual nifedeline, 10 -20 mg sublingually or orally every 30 mins for a maximum of 50 mg, is an effective alternative (26, 27, 31) . Occasionally patients receiving magnesium sulfate along with nifedipine may develop neuromuscular blockade and muscle weakness, which can be reversed by intravenous administration of 10 mL of 10% calcium gluconate (27) . Rarely, intravenous nitroglycerine or sodium nitroprusside infusions may be required for severe refractory hypertension (11) . In addition to the usual adverse effects of these drugs, sodium nitroprusside may cause cyanide accumulation in the fetus after Ͼ4 hrs of administration (26) .
Intracranial Hemorrhage
Intracranial hemorrhage is a rare but serious disorder that accounts for approximately 1% of ICU admissions (1) and carries a mortality of 40% to 70% (2, 12, 14) . (33) . The relative risk of intracerebral hemorrhage during pregnancy and the 6 wks after pregnancy was 5.6 times that for nonpregnant patients. The relative risk of bleeding during pregnancy was 2.5 (95% confidence interval, 1.0 -6.4) and increased to 18.2 (95% confidence interval, 8.7-38.1) in the immediate postpartum period (33) .
Subarachnoid hemorrhage occurs in one to two per 10,000 pregnancies (14, 34) . There is a three-fold increased risk of subarachnoid hemorrhage during pregnancy, and Ͼ 85% of subarachnoid hemorrhages occur in the second or third trimester (11, 14) . The risk of bleeding continues into the puerperal period (14) . Theoretical explanations for the increased risk of hemorrhage during pregnancy include an increase in blood volume, stroke volume, and cardiac output. Hormone-induced vasodilatation and changes in the vessel wall structure have also been suggested as contributory mechanisms (11, 33, 34) . Straining during labor would seem to make this a particularly high-risk period (11), but surprisingly, only few aneurysms bleed during labor (33) . The clinical manifestations and course of subarachnoid hemorrhage during pregnancy are the same as those in nonpregnant patients. Approximately 50% of nonpregnant patients die of the initial aneurysmal bleeding, and if untreated, another 25% to 35% die because of recurrence of the bleeding during the first 2 wks (11, 35) (11, 36) .
A review of 156 cases by Dias and Sekhar suggests that patients treated with early surgery have better maternal and fetal outcomes than those treated conservatively (35) . Most conscious patients with less than severe deficits (grades I to III on the Hunt and Hess scale) are subjected to early aneurysm clipping within the first 4 days after the bleeding (35, 36) . Postoperative cerebral vasospasm may develop and is treated by volume expansion and induced hypertension after the aneurysm has been clipped (11, 36) . The safety for pregnant patients of nimodipine, a dihydropyridine calcium channel blocker shown to be of some benefit in the treatment of vasospasm, is still unclear (11, 12, 32, 36) . Patients with severe neurologic deficits are treated with medical supportive therapy until their condition improves because the operative mortality is extremely high among these patients (11, 36) .
In the past decade, endovascular treatment of aneurysms with detachable metallic coils by interventional radiology has been increasingly used for nonpregnant patients (37) . The experience with this technique in pregnant patients is limited because of the hazards of fetal exposure to x-rays. Abdominal shielding, combined with improvement in angiographic equipment, has considerably reduced the risk to the fetus (37). Nevertheless, patients undergoing endovascular treatment in the first trimester should be offered the option of termination of pregnancy because fetal risk is still considerable at this time (37) . Normal vaginal delivery is safe for patients with successfully obliterated aneurysms, and obstetric considerations should guide decisions about the mode of delivery (11) . The second stage of labor should be shortened (11) .
Bleeding from a cerebral arteriovenous malformation is another important cause of intracranial hemorrhage in pregnancy. Whereas arteriovenous malformations form only 4% to 5% of all intracranial hemorrhages in nonpregnant individuals, they account for almost 50% of intracranial hemorrhages in pregnant patients (38) . As with berry aneurysms, hemodynamic alterations and vessel wall changes due to the effects of sex hormones are believed to increase the risk of rupture in pregnancy (10, 11, 38) . The risk is maximum during the first pregnancy, and hypertension due to preeclampsia may be an additional risk factor (38) . After the initial hemorrhage, 27% to 30% of arteriovenous malformations tend to rebleed in pregnancy (38) . The diagnosis is made by CT or MRI and cerebral angiography (10, 11, 39) . Immediate treatment consists of administration of antiepileptic drugs and measures to reduce intracranial pressure (11, 38, 39) . Definitive treatment is surgical excision, although endovascular treatment and radiosurgery are valuable options in selected cases (11, 38) . The timing of surgery in pregnant patients is controversial, and a recent review suggests that urgent surgery may benefit comatose patients with a large hematoma (38) . Smaller hemorrhages may be treated conservatively and surgical excision may be deferred until after delivery (38) . Although earlier investigators advocated cesarean sections for all patients with arteriovenous malformations, many investigators now believe that normal delivery is safe, provided hemodynamic stresses are minimized with epidural anesthesia and the second stage is shortened with use of outlet forceps (38, 39) .
Cerebral Venous Sinus Thrombosis
Cerebral venous thrombosis, usually associated with dural sinus thrombosis, traditionally has been associated with pregnancy, and 12% of all cases in a series of 624 patients in a large international cohort had pregnancy-related cerebral venous thrombosis (40) . There may be some geographic differences in the incidence of cerebral venous thrombosis. In a series of 49 Taiwanese patients with stroke during pregnancy, Jeng et al. (41) found that 11 (22%) had cerebral venous sinus thrombosis. In contrast, there was only one case of cerebral venous sinus thrombosis in a series of 31 patients with pregnancy-related stroke reported by Kittner et al. from the United States (33) . In a series of 754 obstetric patients admitted to the ICU of the King Edward Memorial Hospital, in Mumbai, India, over a 10-yr period, 26 admissions (3.5%) were for cerebral venous sinus thrombosis (1) . During the same period, there were no patients with this diagnosis in a series of 174 obstetric patients admitted to an ICU in Houston (1). Thus, cerebral venous sinus thrombosis seems to be more common in Asia than in North America and Europe. Whether this is due to ethnic differences or to suboptimal medical care during delivery and the postpartum period is not clear.
There is a 120% to 300% increase in circulating levels of clotting factors during pregnancy (1) . Levels of factors II, VII, and X are also increased. The level of protein S is decreased, but that of protein C remains unchanged (42) . These changes, along with an inhibited fibrinolytic system, result in a marked increase in fibrin generation during pregnancy and puerperium (42) . This hypercoagulable state, along with conditions resulting in dehydration during labor and puerperium, may be responsible for thrombotic complications in pregnancy, including cerebral venous thrombosis (1, 2). Risk factors associated with pregnancy-related cerebral venous sinus thrombosis are maternal age, hyperemesis, delivery by cesarean section, intercurrent infection, and maternal hypertension (43) . In a recent report, Jeng et al. (41) noted that 64% of their 11 patients with pregnancyassociated cerebral venous thrombosis were in a hypercoagulable state: four had protein S deficiency, one had protein C deficiency, and one each had systemic lupus erythematosus and antiphospholipid syndrome.
Only a small proportion of patients develop cerebral venous sinus thrombosis during pregnancy, and 66% to 80% of cases occur during puerperium (1, 40) . Headache is the commonest symptom of cerebral venous thrombosis and occurs in 95% of patients (43) . Other manifestations include focal seizures (47%), paresis (43%), papilledema (41%), altered consciousness (39%), and isolated intracranial hypertension (20%) (43) . The diagnosis is made by contrast-enhanced CT, which shows bilateral infarcts (Fig. 1 ) that are often hemorrhagic (11, 43) . The classic sign of superior sagittal sinus thrombosis is the empty delta sign (Fig.  1) , where the dural margins of the posterior part of the superior sagittal sinus are enhanced by the contrast medium but the clot in the lumen is seen as a triangular filling defect (11, 43) . Less commonly, thrombosis affects the deep cerebral venous system, producing bilateral thalamic and basal ganglial infarction (Fig. 2) . MRI with venography or cerebral angiography (Fig. 3) is diagnostic (43) .
Treatment of cerebral venous sinus thrombosis with unfractionated heparin or low-molecular-weight heparin has been shown to be safe and effective, even in patients with a preexisting intracranial hemorrhage (11, 41, 43) . The activated partial thromboplastin time is maintained at twice the baseline value. For patients who are comatose or whose conditions deteriorate in spite of heparin, some centers have tried local thrombolysis with microcatheters positioned in the thrombosed dural sinus (43) . Recombinant tissue type plasminogen activator or urokinase has been used with variable success. Our own experience with local thrombolysis, via a catheter placed in the superior sagittal sinus in postpartum patients with cerebral venous thrombosis, has been quite encouraging (Fig. 3) . Supportive treatment includes measures to reduce intracranial pressure, administration of anticonvulsant drugs, and adequate hydration (10, 11, 43) .
The in-hospital mortality for pregnancy-related cerebral venous sinus thrombosis is 25% to 30% (2, 14) . A study of pregnant and nonpregnant patients followed up for a median of 16 months showed that 57% had no symptoms, 22% had minor deficits, 5% had moderate or severe deficits, and 8% had died (40) . Fourteen percent of patients develop recurrent seizures as a long-term sequela (44) . Recurrence of venous thrombosis during subsequent pregnancy was seen in none of 39 patients with pregnancyrelated cerebral venous sinus thrombosis (45) .
Cerebral Malaria
Plasmodium falciparum malaria, a mosquito-borne protozoal infection, is mainly distributed in tropical regions of Africa, Asia, and South America (46) . In approximately 1% of individuals, the infection can result in severe life-threatening complications, and it is responsible for 5,000 deaths daily (47) . Cerebral malaria is the commonest and most dreaded complication of falciparum malaria (48) . Pregnant patients, especially nonimmune travelers from areas in which the infection is nonendemic, are particularly susceptible to severe malaria (46) . Even patients residing in areas of endemicity tend to lose their immunity against P. falciparum, and hence severe malaria accounts for 10% of admissions of obstetric patients to the ICU in Mumbai, India (48) .
After an incubation period of 2 wks, during which they proliferate in the liver, parasites invade circulating erythrocytes and multiply (46, 47) . At a particular stage of their lifecycle, parasites make the erythrocytes adhere to each other, as well as to capillary endothelium, resulting in microcirculatory occlusion and tissue hypoxia (46, 49) . The infected red blood cells rupture every 48 hrs, liberating six to 32 new merozoites, which invade new erythrocytes. Tissue ischemia due to microvascular obstruction, endothelial damage, intravascular hemolysis, anemia, and inflammatory cytokines are implicated in the organ dysfunction seen in severe malaria (46, 49) .
Clinical features of cerebral malaria are high fever with chills and rigors and splenomegaly. After 3-7 days of fever, patients develop drowsiness, vomiting, seizures, and coma (46, 48, 50) . At times, seizures develop within 24 hrs of onset of fever (50) . Besides cerebral involvement, 43% of patients with severe malaria have multiple organ failure (48) . Severe thrombocytopenia is seen in 48%, acute renal failure in 30%, hepatic failure in 24%, acute respiratory distress syndrome in 14%, and shock in 17% (48) . Massive intravascular hemolysis requiring multiple blood transfusions occurs in 76%. Pregnant patients have a higher incidence of cerebral involvement, hypoglycemia, and acute respiratory distress syndrome (46) . The diagnosis is made by microscopic examination of the peripheral blood smear, which shows ring forms of P. falciparum within red blood cells. The number of infected cells as a percentage of all red blood cells in the high-power field is referred to as the parasite index, and a parasite index of Ն10% carries a poor prognosis (46) . Rapid diagnostic tests are available, which detect malarial antigens by a dipstick method. These tests may be useful when an experienced microscopist is not available (51) . Patients with severe malaria must be treated in the ICU, and a significant proportion of patients require mechanical ventilation or dialysis (47, 48, 50) . Intravenous quinine is the drug of choice and is safe for pregnant patients (52) . The dose is 10 mg/kg body weight (maximum dose, 600 mg), given as an infusion every 8 hrs. After the initial 24 hrs, the drug may be administered orally (46) . Adverse effects include tinnitus and impaired hearing, but these do not necessitate dose reduction (46) . Electrocardiographic monitoring should be done daily for development of QT prolongation, which requires temporary withdrawal of the drug and reintroduction at a lower dose after normalization of the QT interval (46) . Rarely, patients may develop ocular toxicity, which requires prompt withdrawal of the drug. Artemesinin derivatives are increasingly being used in regions where quinine resistance is common (46, 48) . These drugs are presumably safe in pregnancy, although experience with these drugs in pregnancy is limited. Patients with cerebral malaria will also require anticonvulsant drugs, measures to decrease intracranial pressure, and close monitoring for development of hypoglycemia (46, 48 -50) . The overall mortality associated with severe malaria is approximately 10% to 25%, even among pregnant patients (48, 50) .
Myasthenia Gravis
Myasthenia gravis is common in females of child-bearing age in the second and third decades of life (53, 54) . In a series of 161 pregnant patients with neurologic disorders, To et al. (12) found that five patients had myasthenia gravis. About 30% to 41% of patients experienced a worsening of myasthenia gravis in relation to pregnancy, half during pregnancy and the rest in the postpartum period (53) (54) (55) (56) . The risk of deterioration is highest in patients who become pregnant during the first year after diagnosis; it progressively decreases thereafter (53, 54) . Intercurrent infection during pregnancy or puerperium can precipitate a myasthenic crisis with respiratory paralysis (10, 53, 56) . Some studies have shown increased rates of premature delivery and perinatal death among patients with myasthenia gravis (56) .
Pregnancy of patients with myasthenia gravis should be planned on the basis of the stage of the disease and the treatment being administered. Anticholinesterase medications are continued during pregnancy (53, 54) , but the dose may have to be increased because the rate of gastric emptying and drug absorption decreases in pregnancy (56) . Corticosteroids are also continued during pregnancy (class B: the chance of fetal harm is remote but remains a possibility), in spite of the increased risk of cleft palate in the fetus (54, 56) . Azathioprine is used for patients not responding to corticosteroids (56) ; this drug has been classified as a class D drug (studies in humans have shown evidence of fetal risk, but the potential benefits from the use of the drug by pregnant patients outweigh the risk) (54) . High doses may cause chromosomal damage and immune and bone marrow suppression in the fetus (56) . Cyclosporine A also has been used (54, 56) . This drug causes low birth weight, prematurity, spontaneous abortion, transient neonatal thrombocytopenia, neutropenia, and lymphopenia (56) . However, it is a class C drug (adequate, well-controlled human studies are lacking, and there is a chance of fetal harm if the drug is administered during pregnancy, yet the potential benefits outweigh the risk) (54) . Plasmapheresis of intravenous immunoglobulins is reserved for patients in a myasthenic crisis requiring mechanical ventilation (53, 56) .
Therapeutic abortion has no role in the management of myasthenia gravis (53, 54, 56) . A majority of patients deliver normally, and cesarean section is done only for obstetric indications. Preeclampsia may supervene in some patients with myasthenia. Magnesium sulfate should not be administered to these patients because it may result in severe muscle weakness (56) . Other drugs that worsen myasthenia include aminoglycoside antibiotics, and anesthetic agents such as halothane and isoflurane also should be avoided (54, 56) . Tests of fetal monitoring that involve studying changes in fetal movements or fetal heart rate are not reliable in myasthenic patients, and alternative methods of fetal assessment are preferred (56) . Patients' conditions should be carefully monitored in the postpartum period for deterioration (53) . About 10% to 20% of newborn children of myasthenic mothers develop neonatal myasthenia gravis because of transplacental transfer of maternal antiacetylcholine receptor antibodies (53, 56) . Symptoms develop after 12 hrs and may last for up to 3 months after delivery (56) . In some cases these may be severe enough to cause respiratory failure requiring mechanical ventilation (53) .
Other Disorders
Multiple sclerosis is common in patients of childbearing age, and the effect of pregnancy on the natural course of the disease has been well documented (11, 57, 58) . A large multicenter study has shown that the risk of relapse is reduced during pregnancy but increases significantly in the first 3 months after delivery (58) . Although there are reports of use of ␤-interferon and glatiramer for prevention of relapse or progression of multiple sclerosis during pregnancy, the safety of these drugs in pregnancy has not been established (11, 12, 57) . The disease has no effect on fertility or rate of miscarriage and prematurity and does not require any modification of the mode of delivery (57) . Obstetric considerations determine the need for delivery by cesarean section, and spinal and epidural anesthesia can be safely administered to patients with multiple sclerosis (11, 57) .
Viral hepatitis is a common cause of fulminant hepatic failure during pregnancy in economically developing countries such as Mexico, Pakistan, and India (4, 59, 60) . Hepatitis A virus, spread by the fecal-oral route, is the commonest cause of acute hepatitis in these regions, but most individuals acquire natural immunity to this virus following infection during childhood (61) . Hepatitis E infection, which occurs as water-borne epidemics in South Asia, is the commonest form of viral hepatitis in pregnancy (59, 62) . Jaiswal et al. (59) studied 127 pregnant patients with acute hepatitis in India. Of these cases, 58% were due to hepatitis E, 1% were due to hepatitis A, 1% were due to hepatitis D, and 19% were due to hepatitis B; 22% were negative for hepatitis A through E. Whereas the severity of hepatitis caused by hepatitis A, B, and C in pregnant patients is comparable to that in nonpregnant patients, that caused by hepatitis E tends to be more severe in pregnant patients (60, 62) . Among pregnant patients with hepatitis E infection, 30% to 60% may develop fulminant hepatic failure (59, 62) . Treatment consists of dietary protein restriction, administration of lactulose and oral nonabsorbable antibiotics, and measures to reduce intracranial pressure (63) . Hypoglycemia is common and must be prevented (63) . There is no evidence that termination of pregnancy or urgent delivery alters the course of acute viral hepatitis; hence, viral hepatitis must be differentiated from acute fatty liver of pregnancy, for which urgent delivery improves maternal outcome (60) . About 66% of patients may have preterm delivery (62) . Coagulopathy is common and can be severe. Correction of the coagulopathy with fresh frozen plasma is necessary before vaginal delivery or cesarean section (63) . Vertical transmission of hepatitis B occurs during delivery in 80% to 90% of pregnancies with acute hepatitis in the third trimester (60) . It can be prevented by administration of hepatitis B hyperimmune globulin to the newborn infant, along with the hepatitis B vaccine (60) . Vertical transmission of hepatitis C occurs in 6.7% and hepatitis E in 33% of cases (62, 64) . Despite intensive care, mortality associated with fulminant hepatic failure due to viral hepatitis ranges from 60% to 70% (2, 13, 59) .
Acute intermittent porphyria is an inherited deficiency of the enzyme porphobilinogen deaminase (65) . This disorder may worsen during pregnancy and sometimes manifests for the first time during pregnancy (10, 16) . Common presentations include seizures, altered mental status, abnormal behavior due to cerebral involvement, quadriparesis due to an axonal peripheral motor neuropathy, and abdominal pain and hypertension due to involvement of autonomic nerves (65) . Hyponatremia is also common and may aggravate the neuropsychiatric manifestations (65) . Many of these manifestations closely mimic those of eclampsia, and porphyria must be considered in all patients presenting with seizures for the first time in pregnancy (16) . Patients may require intensive care for refractory status epilepticus or respiratory paralysis due to the motor neuropathy.
The diagnosis is made by testing urine for ␦-aminolevulinic acid and porphoblinogen (65) . Stress, starvation, and hormonal changes during pregnancy may aggravate the disease (10, 16) . Infections, alcohol, and drugs that induce hepatic synthesis of porphyrins are the commonest precipitating factors (10) . These include drugs such as clonazepam, phenytoin, phenobarbital, and valproic acid, which are commonly used to treat seizures. These drugs may worsen seizures, and therefore refractory status epilepticus is a common presentation (65) . Ergot alkaloids also are contraindicated (10, 16) . Treatment consists of administration of large quantities of glucose (200 -500 g/d) by the parenteral and enteral routes. Patients with more severe disease respond to intravenous infusion of hematin (10, 16) .
CONCLUSION
Neurologic manifestations in the form of coma, seizures, or paralysis are commonly encountered in obstetric patients in the intensive care unit. Specific concerns during pregnancy include the effects of the disease on the fetus, safety of drugs and diagnostic modalities in pregnancy, effects of pregnancy on the course of the disease, and the need to intervene during labor and delivery to prevent exacerbation of the disease and reduce risk to both mother and fetus. Obstetric patients admitted to the ICU with medical disorders have a poor prognosis, especially if intracranial hemorrhage is present. Better prenatal care can prevent many of these neurologic complications. Good prenatal care has considerably decreased the risk of eclampsia in developed countries, but this is still a common indication for ICU admission in developing countries. Infections such as acute viral hepatitis and cerebral malaria are important conditions requiring intensive care during pregnancy and are at times diffi- cult to differentiate from obstetric disorders such as acute fatty liver of pregnancy or eclampsia because of the substantial overlap in their manifestations. Invariably, patients will have failure of other organs as well. Comatose patients may also have disseminated intravascular coagulopathy, acute renal failure, hepatic failure, or acute respiratory distress syndrome. The resulting problems can be very complicated and require close coordination between the neurologist, neurosurgeon, obstetrician, and intensivist in order to give the mother and fetus the best chance of recovery.
